Synopsis of recent research by authors named "Ivan Greguric"
- Ivan Greguric's recent research focuses on the development and evaluation of novel radiopharmaceuticals, specifically targeting neuroinflammation, cancer, and metabolic disorders through innovative synthesis techniques and pharmacological assessments.
- Prominent studies include the synthesis of [F]PBR316, a PET ligand designed for greater specificity and lower sensitivity to genetic variations, and pH-responsive polymers to improve hypoxia imaging accuracy in cancer diagnostics.
- Greguric's work also involves optimizing radiotracer production methods, exploring metal ion interactions in radiolabeling, and advancing the understanding of antidepressant potential through the study of analogs of known transport blockers.